| Dr Walt John Unruh, PHARMD | |
|
600 Caisson Hill Road, Irwin Community Hospital, Department Of Pharmacy, Ft. Riley, KS 66442-7037 | |
| (785) 239-7411 | |
| (785) 239-7239 |
| Full Name | Dr Walt John Unruh |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 600 Caisson Hill Road, Ft. Riley, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770855629 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 41898 (Texas) | Secondary |
| 183500000X | Pharmacist | 1-13147 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Walt John Unruh, PHARMD 600 Caisson Hill Road, Irwin Community Hospital, Department Of Pharmacy, Ft. Riley, KS 66442 Ph: (785) 239-7411 | Dr Walt John Unruh, PHARMD 600 Caisson Hill Road, Irwin Community Hospital, Department Of Pharmacy, Ft. Riley, KS 66442-7037 Ph: (785) 239-7411 |
News Archive
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has secured an exclusive worldwide license from Bioclassifier, LLC to develop in vitro diagnostic and research products for breast cancer intrinsic subtyping.
Communicating food benefits to children that they can relate to may get them to eat healthier. That's according to a study published today in the Journal of Nutrition Education and Behavior by Washington State University and Florida State University scientists.
A new report by UnitedHealth Group's Center for Health Reform & Modernization finds that a majority of physicians are utilizing genetic testing. The report, titled "Personalized Medicine: Trends and prospects for the new science of genetic testing and molecular diagnostics," presents new findings on how genetic tests can help diagnose disease, target prevention, and ensure that patients receive the medicines that will best treat their conditions.
The management of children with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis has evolved significantly over the past decade. With a surge of pediatric research in the field, quality of life has become an important focus of study, as indicated by the number of related abstracts that will be presented at the 2010 Advances in Inflammatory Bowel Diseases, the Crohn's & Colitis Foundation's Clinical & Research Conference beginning tomorrow in Hollywood, Florida.
› Verified 8 days ago